A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02886715|
Recruitment Status : Completed
First Posted : September 1, 2016
Results First Posted : August 17, 2018
Last Update Posted : August 17, 2018
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Double (Participant, Investigator); Primary Purpose: Treatment|
Drug: Tazarotene Cream 0.1%
|Recruitment Details||At Baseline Visit eligible subjects were randomized to the Test, Reference or Placebo product in a 2:2:1 ratio using an interactive response technology (IRT) system|
1154 subjects were screened for study participation, 1110 subjects were randomized and included in the statistical analyses.
25 investigative sites randomized subjects into the study.